Holen Sie sich die Stockscreener-App
57.00
0.44%
-0.25
Schlusskurs vom Vortag:
$57.25
Offen:
$57.19
24-Stunden-Volumen:
8,517
Relative Volume:
0.17
Marktkapitalisierung:
$1.81B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-32.61M
KGV:
-48.54
EPS:
-1.1742
Netto-Cashflow:
-
1W Leistung:
+1.79%
1M Leistung:
-2.10%
6M Leistung:
+15.83%
1J Leistung:
+26.30%
1-Tages-Spanne:
$57.00
$57.58
1-Wochen-Bereich:
$55.90
$58.54
52-Wochen-Spanne:
$31.00
$86.53
Belite Bio Inc Adr Stock (BLTE) Company Profile
Firmenname
Belite Bio Inc Adr
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie BLTE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BLTE
Belite Bio Inc Adr
|
57.00 | 1.81B | 0 | -32.61M | 0 | -1.1742 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.24 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
700.33 | 76.56B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
644.48 | 39.16B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
250.59 | 32.44B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
120.01 | 28.77B | 3.30B | -501.07M | 1.03B | -2.1146 |
Belite Bio Inc Adr Stock (BLTE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-12-14 | Eingeleitet | Maxim Group | Buy |
| 2023-07-28 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-07-26 | Eingeleitet | SVB Securities | Outperform |
| 2022-08-01 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-07-01 | Eingeleitet | The Benchmark Company | Buy |
Belite Bio Inc Adr Aktie (BLTE) Neueste Nachrichten
Belite Bio, Inc (NASDAQ:BLTE) Short Interest Down 9.2% in January - MarketBeat
Belite Bio (NASDAQ:BLTE) Stock Price Up 7.8%Should You Buy? - MarketBeat
Belite Bio (NASDAQ:BLTE) Shares Down 4.7%Time to Sell? - MarketBeat
Advisors Preferred LLC Purchases New Shares in Belite Bio, Inc (NASDAQ:BLTE) - Armenian Reporter
Belite Bio Announces $15 Million Direct Offering to Enhance Financial Position - TipRanks
BLTEBelite Bio, Inc American Depositary Shares Latest Stock News & Market Updates - StockTitan
Sangoma Announces Second Quarter Fiscal 2025 Results - The Globe and Mail
Why Oklo Stock Jumped 96% in January - The Globe and Mail
Belite Bio Raises Fresh Capital: $30M Total Potential as Clinical Programs Advance - StockTitan
Belite Bio Announces Registered Direct Offering of $15 Million - GlobeNewswire Inc.
Flow Beverage Corp. Adds José Bautista as Strategic Advisor and Closes Second Tranche of Private Placement of Convertible Debenture Units - The Globe and Mail
Why Dominion Energy Stock Was Falling Today - The Globe and Mail
Leerink Partnrs Increases Earnings Estimates for Belite Bio - MarketBeat
Belite Bio, Inc (NASDAQ:BLTE) Stake Increased by JPMorgan Chase & Co. - MarketBeat
Where Will Nvidia Stock Be in 3 Years? - The Globe and Mail
Apple Stock Is Off Its Recent Highs, But Is It Poised to Rise Again? - The Globe and Mail
Short Interest in Belite Bio, Inc (NASDAQ:BLTE) Decreases By 60.3% - MarketBeat
Bitcoin: Buy the Dip? - The Globe and Mail
JPMorgan Chase & Co. Grows Stock Holdings in Belite Bio, Inc (NASDAQ:BLTE) - Defense World
Is Coffee Moving to Even Higher Highs? - The Globe and Mail
Charter (CHTR) Reports Q4: Everything You Need To Know Ahead Of Earnings - The Globe and Mail
Are These Renewable Energy Stocks in Trouble, or Are They Ultra-Cheap Buys? - The Globe and Mail
The Ultimate Growth Stock to Buy With $1,000 Right Now - The Globe and Mail
Rigetti CEO Responds to Jensen Huang and Mark Zuckerberg on the Future of Quantum Computing - The Globe and Mail
Avoid the Trap: 3 High-yield Dividend Stocks With Safe Payouts - The Globe and Mail
2 Artificial Intelligence Stocks You Can Buy and Hold for the Next Decade - The Globe and Mail
4 Soaring Stocks I'd Buy Now With No Hesitation - The Globe and Mail
Analysts Predict 1,250% Upside for This ‘Strong Buy’ Quantum Computing Stock in 2025... But Investors Should Stay Away - The Globe and Mail
XFRA : ICFFRENDE DER HANDELSUNTERBRECHUNG IN DIVERSEN AKTIENTEIL 2 () - Aktiencheck
Belite Bio (NASDAQ:BLTE) Shares Gap Up After Analyst Upgrade - Defense World
Belite Bio (NASDAQ:BLTE) Shares Gap Up Following Analyst Upgrade - MarketBeat
Benchmark Issues Positive Forecast for Belite Bio (NASDAQ:BLTE) Stock Price - Defense World
Benchmark Boosts Belite Bio (NASDAQ:BLTE) Price Target to $79.00 - MarketBeat
Benchmark sees growth for Belite Bio shares, highlights Tinlarebant's promise in rare diseases - Investing.com
ATS to Participate in the Citi Global Industrial Tech and Mobility Conference - The Globe and Mail
Belite Bio (NASDAQ:BLTE) Trading 5.4% HigherHere's Why - MarketBeat
Belite Bio (NASDAQ:BLTE) Sees Unusually-High Trading VolumeWhat's Next? - MarketBeat
Belite Bio, Inc (NASDAQ:BLTE) Short Interest Down 60.3% in December - MarketBeat
GAMMA Investing LLC Buys 419 Shares of Belite Bio, Inc (NASDAQ:BLTE) - Defense World
If You'd Invested $1,000 in Tesla Stock 10 Years Ago, Here's How Much You'd Have Today - The Globe and Mail
Belite Bio (NASDAQ:BLTE) Shares Down 4.2%Should You Sell? - MarketBeat
Belite Bio, Inc (NASDAQ:BLTE) Shares Purchased by State Street Corp - Defense World
What is HC Wainwright’s Estimate for MetaVia Q4 Earnings? - Defense World
Short Interest in Belite Bio, Inc (NASDAQ:BLTE) Declines By 12.9% - MarketBeat
Finanzdaten der Belite Bio Inc Adr-Aktie (BLTE)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.27%
3.05%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):